Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantati… (NCT07530913) | Clinical Trial Compass
By InvitationNot Applicable
Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients
South Korea36 participantsStarted 2026-03-26
Plain-language summary
This randomized controlled study aims to evaluate the effectiveness of a digital rehabilitation exercise platform in patients undergoing living donor liver transplantation. A total of 36 adult patients who require ongoing rehabilitation after living donor liver transplantation will be recruited and randomly assigned in a 1:1 ratio to either an intervention group or a control group. The intervention group will receive a personalized exercise program delivered through a digital rehabilitation platform in addition to standard exercise education, whereas the control group will receive standard exercise education only. Physical function, body composition, quality of life, and physical activity will be assessed before surgery, at discharge, at 1 month after discharge, and at 3 months after discharge to determine whether the digital rehabilitation platform improves recovery-related outcomes during the post-transplant period.
Who can participate
Age range
20 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients undergoing living donor liver transplantation who require continuous rehabilitation treatment
* Adults aged 20 to 65 years
* Able to independently operate digital devices such as a smartphone or tablet PC
* Able to perform exercises and review feedback using the digital rehabilitation platform
* No significant impairment in hearing, vision, or cognitive function that would interfere with understanding audio and visual instructions provided by the platform
Exclusion Criteria:
* Patients with an inadequate level of consciousness or cognitive impairment making cooperation with the rehabilitation exercise program difficult
* Patients who have difficulty using digital devices or cannot independently use digital-based services
* Patients with severe limitations in muscle strength or range of motion, or amputation-related disability, making the exercise program difficult to perform
* Patients who require restriction of movement necessary for the rehabilitation exercise program due to fracture or musculoskeletal instability
* Patients with pain during upper or lower extremity movement and biomechanical instability that makes participation difficult
* Patients with visual or hearing impairment that interferes with cooperation in the rehabilitation exercise program
* Patients who develop medical complications or transplant rejection during study participation
* Patients unable to perform physical activity because of abdominal pain
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
6-Minute Walk Distance in meters
Timeframe: Baseline (preoperative admission), on the day of hospital discharge from the index transplantation admission, 1 month after discharge, and 3 months after discharge